The ASX-listed pharmaceutical company is selling its Australian manufacturing and commercial operations to Australian-owned Evaris Pharma as it shifts its focus entirely to the US.
The ASX-listed pharmaceutical company is selling its Australian manufacturing and commercial operations to Australian-owned Evaris Pharma as it shifts its focus entirely to the US.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.